Amino Acid Sequence

Amino Acid Sequence designates the specific linear order of amino acid residues in a protein or peptide, determined by the underlying genetic code and representing the primary structure that dictates all higher order molecular properties. This sequence, typically written from the N terminus to C terminus using standard one letter or three letter codes, contains complete information necessary for protein folding, function, and biological activity. Even single amino acid substitutions can dramatically impact therapeutic protein stability, immunogenicity, and efficacy.

In biologics development, amino acid sequence characterisation serves as a critical quality attribute requiring extensive analytical verification throughout manufacturing. Regulatory agencies demand complete sequence confirmation using orthogonal techniques including mass spectrometry, Edman degradation, and peptide mapping to ensure product identity and consistency. For biosimilars, demonstrating sequence identity to reference products constitutes a fundamental requirement in establishing comparability. The industry faces unique challenges with post translational modifications, sequence variants from host cell expression systems, and potential degradation pathways that alter primary structure. Biopharmaceutical companies invest in sophisticated analytical platforms capable of detecting and quantifying sequence heterogeneity at trace levels. As novel protein engineering techniques enable incorporation of non natural amino acids and complex fusion constructs, sequence verification becomes increasingly sophisticated. Understanding how amino acid sequence influences developability, manufacturability, and immunogenic potential guides rational design of next generation therapeutics with optimised clinical profiles and manufacturing characteristics.